Before administration, fetal RBCs are quantitated in order to determine the proper dose of RhIG.
RhIG is IgG antibody. It will cross the placenta and can cause a weakly positive DAT in the fetus/infant. However, the titer of anti-D is too weak to cause any clinically significant RBC destruction.